Seguimiento farmacoterapéutico en problemas relacionados con medicamentos en diabéticos en un Hospital nivel III de Trujillo-Perú
No Thumbnail Available
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El trabajo de investigación tuvo como objetivo principal determinar el efecto del seguimiento farmacoterapéutico en problemas relacionados con medicamentos en diabéticos en un Hospital nivel III de Trujillo-Perú. La metodología del estudio es descriptivo retrospectivo y para la intervención se empleó el método SOAP siguiendo el procedimiento de las BPOF, se contó con 21 pacientes entre 35 a 90 años durante un periodo de 6 meses. Se determinó que la población más prevalente con DM2 fue la femenina con 61,9% y el grupo etario más prevalente fue de 71 a 75 años con el 23,8%, además el seguimiento farmacoterapéutico permitió controlar parámetros clínicos como glucosa en ayunas (76,2%), glucosa posprandial (81%), HbA1c% (76,2%), presión arterial (85,7%), colesterol LDL (66,7%), triglicéridos (61,9%), excepto el IMC (33,3%); los PRM más prevalentes fueron por efectividad (41,1%), seguridad (35,6%), y por último, por necesidad (23,3%), de los cuales se resolvieron el 84,9% de PRM, con la elaboración de 70 intervenciones farmacéuticas, que fueron por cantidad de medicamento (38,6%) y estrategia farmacológica (61,4%), de las cuáles se aceptaron 65 (92,9%) intervenciones que resolvieron PRM en un 95,4% y no resolvieron en un 4,6%, y se rechazaron 5 (7,1%) intervenciones. Finalmente, se concluyó que el seguimiento farmacoterapéutico mediante la evaluación de la necesidad, efectividad y seguridad del tratamiento farmacológico permitió detectar y resolver favorablemente los PRM en diabéticos, permitiendo optimizar su farmacoterapia.
ABSTRACT The main objective of this research was to determine the effect of pharmacotherapeutic follow-up on drug-related problems in diabetic patients in a level III hospital in Trujillo- Peru. The methodology of the study is retrospective descriptive and for the intervention the SOAP method was used following the BPOF procedure. 21 patients between 35 and 90 years of age were included for a period of 6 months. It was determined that the most prevalent population with DM2 was female with 61.9% and the most prevalent age group was 71 to 75 years with 23.8%, in addition, pharmacotherapeutic follow-up allowed control of clinical parameters such as fasting glucose (76.2%), postprandial glucose (81%), HbA1c% (76.2%), blood pressure (85.7%), LDL cholesterol (66.7%), triglycerides (61.9%), except for IMC (33.3%); The most prevalent PRM were effectiveness (41.1%), safety (35.6%), and finally, necessity (23.3%), of which 84.9% of PRM were resolved, with the development of 70 pharmaceutical interventions, which were by drug quantity (38.6%) and pharmacological strategy (61.4%), of which 65 (92.9%) interventions were accepted, 95.4% of which resolved PRM and 4.6% were not resolved, and 5 (7.1%) interventions were rejected. Finally, it was concluded that pharmacotherapeutic follow-up through the evaluation of the need, effectiveness and safety of pharmacological treatment allowed the detection and favorable resolution of DRPs in diabetics, making it possible to optimize their pharmacotherapy
ABSTRACT The main objective of this research was to determine the effect of pharmacotherapeutic follow-up on drug-related problems in diabetic patients in a level III hospital in Trujillo- Peru. The methodology of the study is retrospective descriptive and for the intervention the SOAP method was used following the BPOF procedure. 21 patients between 35 and 90 years of age were included for a period of 6 months. It was determined that the most prevalent population with DM2 was female with 61.9% and the most prevalent age group was 71 to 75 years with 23.8%, in addition, pharmacotherapeutic follow-up allowed control of clinical parameters such as fasting glucose (76.2%), postprandial glucose (81%), HbA1c% (76.2%), blood pressure (85.7%), LDL cholesterol (66.7%), triglycerides (61.9%), except for IMC (33.3%); The most prevalent PRM were effectiveness (41.1%), safety (35.6%), and finally, necessity (23.3%), of which 84.9% of PRM were resolved, with the development of 70 pharmaceutical interventions, which were by drug quantity (38.6%) and pharmacological strategy (61.4%), of which 65 (92.9%) interventions were accepted, 95.4% of which resolved PRM and 4.6% were not resolved, and 5 (7.1%) interventions were rejected. Finally, it was concluded that pharmacotherapeutic follow-up through the evaluation of the need, effectiveness and safety of pharmacological treatment allowed the detection and favorable resolution of DRPs in diabetics, making it possible to optimize their pharmacotherapy
Description
Keywords
Seguimiento farmacoterapéutico. Diabetes mellitus tipo 2. Intervención farmacéutica. Problemas relacionados con medicamentos. Diabéticos hospitalizados